traveling with semaglutide vial for weight loss | Blog Travel with Compounded Semaglutide: Complete

PMCID: PMC6305861

Toward More Tailored Dosing Strategies While the panacea of individualised dosing regimens might represent a leap too far in terms of complexity, the opportunity does exist for pharmaceutical companies to implement a more tailored approach when it comes to dosing, arriving at a more delicate balance of drug exposure, bioavailability, efficacy and safety based on the characteristics of certain patient cohorts

"The majority of our members are on a medication of some sort, and it's because they typically struggle with obesity and they've been trying to solve it through a lens of just eat less, exercise more," Found's CEO, Sarah Jones Simmer, told Insider in an interview

Whether the conclusions drawn for licensed GLP-1 receptor agonists will extend to retatrutide a structurally distinct triple agonist with additional glucagon receptor activity remains to be determined through ongoing and future trials